These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 229974)

  • 21. Cellular alterations dependent upon the polyoma virus Hr-t function: separation of mitogenic from transforming capacities.
    Schlegel R; Benjamin TL
    Cell; 1978 Jul; 14(3):587-99. PubMed ID: 210955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Middle T antigen as primary inducer of full expression of the phenotype of transformation by polyoma virus.
    Ito Y; Spurr N; Griffin BE
    J Virol; 1980 Jul; 35(1):219-32. PubMed ID: 6251270
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protein kinase activities in immune complexes of simian virus 40 large T-antigen and transformation-associated cellular p53 protein.
    Van Roy F; Fransen L; Fiers W
    Mol Cell Biol; 1984 Feb; 4(2):232-9. PubMed ID: 6321955
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Common elements in growth factor stimulation and oncogenic transformation: 85 kd phosphoprotein and phosphatidylinositol kinase activity.
    Kaplan DR; Whitman M; Schaffhausen B; Pallas DC; White M; Cantley L; Roberts TM
    Cell; 1987 Sep; 50(7):1021-9. PubMed ID: 2441878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of tumor formation and cell transformation by polyoma middle T antigen in the absence of Src.
    Thomas JE; Aguzzi A; Soriano P; Wagner EF; Brugge JS
    Oncogene; 1993 Sep; 8(9):2521-9. PubMed ID: 7689725
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recombinant retroviruses that transduce middle T antigen cDNAs derived from polyomavirus mutants: separation of focus formation and soft-agar growth in transformation assays and correlations with kinase activities in vitro.
    Morgan WC; Kaplan DR; Pallas DC; Roberts TM
    J Virol; 1988 Sep; 62(9):3407-14. PubMed ID: 2841493
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phosphoinositide kinase activity and transformation.
    Whitman M; Kaplan D; Cantley L; Roberts TM; Schaffhausen B
    Fed Proc; 1986 Oct; 45(11):2647-52. PubMed ID: 3019785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The nucleotide binding site detected by affinity labeling in the large T proteins of polyoma and SV40 viruses is distinct from their ATPase catalytic site.
    Clertant P; Gaudray P; May E; Cuzin F
    J Biol Chem; 1984 Dec; 259(24):15196-203. PubMed ID: 6096361
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Transformation-Defective Polyomavirus Middle T Antigen with a Novel Defect in PI3 Kinase Signaling.
    Denis D; Rouleau C; Schaffhausen BS
    J Virol; 2017 Jan; 91(2):. PubMed ID: 27852846
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polyoma virus transforming protein associates with the product of the c-src cellular gene.
    Courtneidge SA; Smith AE
    Nature; 1983 Jun 2-8; 303(5916):435-9. PubMed ID: 6304524
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The expression and properties of polyoma virus middle-T antigen in simian cells.
    Belsham GJ; Ely BK; Smith AE
    Virus Res; 1986 Feb; 4(2):157-77. PubMed ID: 3010597
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polyomavirus small T antigen controls viral chromatin modifications through effects on kinetics of virus growth and cell cycle progression.
    Dahl J; Chen HI; George M; Benjamin TL
    J Virol; 2007 Sep; 81(18):10064-71. PubMed ID: 17626093
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transformation by polyoma virus is drastically reduced by substitution of phenylalanine for tyrosine at residue 315 of middle-sized tumor antigen.
    Carmichael G; Schaffhausen BS; Mandel G; Liang TJ; Benjamin TL
    Proc Natl Acad Sci U S A; 1984 Feb; 81(3):679-83. PubMed ID: 6322163
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tyrosine phosphorylation within the amino-terminal domain of pp60c-src molecules associated with polyoma virus middle-sized tumor antigen.
    Yonemoto W; Jarvis-Morar M; Brugge JS; Bolen JB; Israel MA
    Proc Natl Acad Sci U S A; 1985 Jul; 82(14):4568-72. PubMed ID: 3927285
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunization against the polyoma virus-induced tumor-specific transplantation antigen by early region mutants of the virus.
    Dalianis T; Magnusson G; Ito Y; Klein G
    J Virol; 1982 Sep; 43(3):772-7. PubMed ID: 6292460
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Separation of host range from transformation functions of the hr-t gene of polyomavirus.
    Garcea RL; Talmage DA; Harmatz A; Freund R; Benjamin TL
    Virology; 1989 Feb; 168(2):312-9. PubMed ID: 2536985
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polyoma virus middle T antigen: relationship to cell membranes and apparent lack of ATP-binding activity.
    Schaffhausen BS; Dorai H; Arakere G; Benjamin TL
    Mol Cell Biol; 1982 Oct; 2(10):1187-98. PubMed ID: 6184609
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of a neuroregulated phosphoprotein in skeletal muscle as the regulatory subunit of cyclic AMP-dependent protein kinase II.
    Squinto SP; McLane JA; Held IR
    J Neurosci Res; 1985; 14(2):217-28. PubMed ID: 2995689
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhancement of cellular src gene product associated tyrosyl kinase activity following polyoma virus infection and transformation.
    Bolen JB; Thiele CJ; Israel MA; Yonemoto W; Lipsich LA; Brugge JS
    Cell; 1984 Oct; 38(3):767-77. PubMed ID: 6091900
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhancement of polyoma virus middle T antigen tyrosine phosphorylation by epidermal growth factor.
    Segawa K; Ito Y
    Nature; 1983 Aug 25-31; 304(5928):742-4. PubMed ID: 6193426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.